Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|
Aug 2020
|
Nature Medicine
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management
|
Aug 2020
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges
|
Aug 2020
|
International Journal of Laboratory Hematology
|
myelodysplastic syndromes (MDS)
|
Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes
|
Aug 2020
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes
|
Aug 2020
|
Cancer
|
myelodysplastic syndromes (MDS)
|
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
|
Aug 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort
|
Aug 2020
|
Pediatric Blood & Cancer
|
aplastic anemia, pediatric
|
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium
|
Aug 2020
|
Pediatric Blood & Cancer
|
aplastic anemia, myelodysplastic syndromes (MDS), pediatric
|
Guideline-based indicators for adult patients with myelodysplastic syndromes
|
Aug 2020
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes
|
Aug 2020
|
Journal of Patient-Reported Outcomes
|
myelodysplastic syndromes (MDS)
|